What is Leiomyosarcoma?
Leiomyosarcoma is a rare type of cancer that affects smooth muscle tissue. These tumors are most common in the abdomen, but can occur anywhere in the body, including the uterus. Other common sites include blood vessels and skin.
How many people are affected by Leiomyosarcoma?
- Annual incidence of leiomyosarcomas is approximately 0.4 to 0.64 per 100,000 women in the United States, which is increasing in postmenopausal women, usually after age 50.
- Leiomyosarcomas affect both males and females.
- Leiomyosarcoma is a form of soft tissue sarcoma. According to the American Cancer Society, at least 15,000 new cases of soft tissue sarcoma occur each year in the U.S.
- According to one estimate, leiomyosarcomas account for 7-11 percent of all cases of soft tissue sarcomas.
How will Leiomyosarcoma Market change in upcoming years?
According to DelveInsight, the Leiomyosarcoma market in 7MM is expected to change in the study period 2017-2030.
The Leiomyosarcoma market report provides current treatment practices, emerging drugs, Leiomyosarcoma market share of the individual therapies, current and forecasted Leiomyosarcoma market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Leiomyosarcoma treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
The Leiomyosarcoma market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Leiomyosarcoma market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
For free sample pages, request here @ Leiomyosarcoma Market Landscape
Scope of the Report
- The report covers the descriptive overview of Leiomyosarcoma , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Leiomyosarcoma epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Leiomyosarcoma are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Leiomyosarcoma market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Leiomyosarcoma market
For free sample pages, request here @ Leiomyosarcoma Market Size